RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

Clinical trial NCT07006805 · WITHDRAWN

Trial details

NCT number: NCT07006805
Sponsor: Cabaletta Bio
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis (RMS)Progressive Multiple Sclerosis (PMS)Multiple Sclerosis - Relapsing Remitting Multiple Sclerosis Multiple Sclerosis (Relapsing Remitting)Multiple Sclerosis (MS) - Relapsing-remitting Progressive Multiple Sclerosis

Start date: 2026-06-01
Primary completion: 2028-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.